NCT04980924

Brief Summary

This survey will allow to identify PE prognostic, but also long-term complications, i.e. recurrence rate, on-treatment bleedings, deep-vein thrombosis sequella, pulmonary hypertension rate, and chronic pulmonary disease rate without PH. This database should help us identify risk-factors for each event.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
547

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 1992

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1992

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 1997

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 1997

Completed
23.6 years until next milestone

First Submitted

Initial submission to the registry

July 21, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 28, 2021

Completed
Last Updated

March 6, 2025

Status Verified

March 1, 2025

Enrollment Period

6 years

First QC Date

July 21, 2021

Last Update Submit

March 5, 2025

Conditions

Pulmonary Embolism

Outcome Measures

Primary Outcomes (1)

  • Reccurence

    number of patient with Documented symptomatic pulmonary embolism reccurence

    10 years

Secondary Outcomes (2)

  • Pulmonary hypertension

    10 years

  • Chronic pulmonary disease without hypertension

    10 years

Study Arms (2)

Pulmonary Embolism without reccurence or complication

Pulmonary Embolism without reccurence or complication

Other: no intervention

Pulmonary Embolism with reccurence or complication

Pulmonary Embolism with reccurence or complication, in particular occurrence of pulmonary hypertension.

Other: no intervention

Interventions

no interventionOTHER

no intervention

Pulmonary Embolism with reccurence or complicationPulmonary Embolism without reccurence or complication

Eligibility Criteria

Age18 Years - 110 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All pulmonary embolisms hospitalised in our department

You may qualify if:

  • All pulmonary embolisms hospitalised in Nice hospital.
  • acceptation to enter in the cohorte survey

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nice University Hospital

Nice, 06000, France

Location

Related Publications (1)

  • Ferrari E, Fourrier E, Asarisi F, Heme N, Redjimi N, Berkane N, Labbaoui M, Breittmayer JP, Bun SS, Moceri P, Squara F. Is pulmonary embolism recurrence linked with the severity of the first event? A French retrospective cohort study. BMJ Open. 2021 Sep 29;11(9):e050910. doi: 10.1136/bmjopen-2021-050910.

    PMID: 34588255DERIVED

MeSH Terms

Conditions

Pulmonary Embolism

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesEmbolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2021

First Posted

July 28, 2021

Study Start

January 1, 1992

Primary Completion

December 31, 1997

Study Completion

December 31, 1997

Last Updated

March 6, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)